Timelines of contraceptive reinjections in South Africa and its relation to unintentional discontinuation

International Family Planning Perspectives

Volumn 33, Issue 2, 2007, Pages 66-74

  Baumgartner, Joy Noel ^a   Morroni, Chelsea ^b   Mlobeli, Regina Dlakulu ^b   Otterness, Conrad ^a   Myer, Landon ^b   Janowitz, Barbara ^a   Stanback, John ^a   Buga, Geoffrey ^c  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c WALTER SISULU UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE USE; PREGNANCY; REGRESSION ANALYSIS;

AFRICA; CAPE PROVINCE; SOUTH AFRICA; SOUTHERN AFRICA; SUB-SAHARAN AFRICA;

CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INJECTION; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; SOUTH AFRICA;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INJECTIONS; INTENTION; PATIENT COMPLIANCE; SOUTH AFRICA;

EID: 34547524134     PISSN: None     EISSN: 01903187     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tolley E et al., The impact of menstrual side effects on contraceptive discontinuation: findings from a longitudinal study in Cairo, Egypt, International Family Planning Perspectives, 2005, 31(1):15-23.
2. Hubacher D et al., Factors affecting continuation rates of DMPA, Contraception, 1999, 60(6):345-351.
3. Paul C, Skegg DCG and Williams S, Depot medroxyprogesterone acetate: patterns of use and reasons for discontinuation, Contraception, 1997, 56(4):209-214.
4. Westfall JM, Main DS and Barnard L, Continuation rates among injectable contraceptive users, Family Planning Perspectives, 1996, 28(6):275-277.
5. World Health Organization (WHO), Selected Practice Recommendations for Contraceptive Use, Geneva: WHO, 2004.
6. WHO, Medical Eligibility Criteria for Contraceptive Use, third ed., Geneva: WHO, 2004.
7. Stanback J et al., Menstrual requirements: a significant barrier to contraceptive access in developing countries, Studies in Family Planning, 1997, 28(3):245-250.
8. Hatcher RA et al., The Essentials of Contraceptive Technology, Baltimore, MD, USA: Johns Hopkins University School of Public Health, Population Information Program, 1997.
9. Medical Research Council, Department of Health of South Africa and Macro International, South Africa Demographic and Health Survey 1998, Pretoria, South Africa: Department of Health, 2001.
10. Magwaza S and Cooper D, An Evaluation of the Community Based Distribution of Contraceptives Programme in Khayelitsha, Cape Town: Qualitative Research-An Operational Report, Cape Town, South Africa: University of Cape Town, 1999.
11. Cooper D and Marks A, An Evaluation of the Community Based Distribution of Contraceptives Programme in Khayelitsha, Cape Town: Follow Up Survey, Cape Town, South Africa: University of Cape Town, 1999.
12. Department of Health of South Africa, National Contraception Policy Guidelines: Within a Reproductive Health Framework, Pretoria, South Africa: Department of Health, 2003.
13. Department of Health of South Africa, National Contraception Service Delivery Guidelines: Within a Reproductive Health Framework, Pretoria, South Africa: Department of Health 2003.
14. Beksinska ME et al., Compliance and use behavior, an issue in injectable as well as oral contraceptive use? a study of injectable and oral contraceptive use in Johannesburg, British Journal of Family Planning, 1998, 24(1):21-23.
15. Beksinska ME, Rees HV and Smit F, Temporary discontinuation: a compliance issue in injectable users, Contraception, 2001, 64(5):309-313.
16. Potter LS, Why must one 'restart' a method that is still working? A case for redefining injectable discontinuation, Family Planning Perspectives, 1999, 31(2):98-100.
17. Morroni C and Moodley J, The role of urine pregnancy testing in facilitating access to antenatal care and abortion services in South Africa: a cross-sectional study, BMC Pregnancy and Childbirth, 2006, Vol. 6, No. 26.
18. Canto De Cetina TE, Canto P and Luna MO, Effect of counseling to improve compliance in Mexican women receiving depot-medroxy-progesterone acetate, Contraception, 2001, 63(3):143-146.
19. Lei ZW et al, Effect of pretreatment counseling on discontinuation rates in Chinese women given depot-medroxyprogesterone acetate for contraception, Contraception, 1996, 53(6):357-361.
20. Stanback J et al., Checklist for ruling out pregnancy among family planning clients in primary care, Lancet, 1999, 354(9178):566.
21. Jewkes RK, Levin JB and Penn-Kekana LA, Gender inequalities, intimate partner violence and HIV preventive practices: findings of a South African cross-sectional study, Social Science & Medicine, 2003, 56(1):125-134.
22. Maharaj P, Obstacles to negotiating dual protection: perspectives of men and women, African Journal of Reproductive Health, 2001, 5(3):150-161.
23. Harrison A, Xaba N and Kunene P, Understanding safe sex: gender narratives of HIV and pregnancy prevention by rural South African school-going youth, Reproductive Health Matters, 2001, 9(17):63-71.
24. Smit JA et al., Where is the condom? Contraceptive practice in a rural district of South Africa, African Journal of Reproductive Health, 2002, 6(2):71-78.